Skip to main content
. 2020 Feb 11;1(1):100001. doi: 10.1016/j.jtocrr.2020.100001

Table 2.

Cancer Mortality Rate in CANTOS

300-mg Dose Group Rate Reduction
Cancer mortality 51% (p = 0.0009)
Lung cancer incidence 67% (p < 0.0001)
Lung cancer mortality 77% (p = 0.0002)